Attilio Losito1, Emidio Nunzi2, Loretta Pittavini2, Ivano Zampi3, Elena Zampi4. 1. Renal Unit, Santa Maria Della Misericordia Hospital, Piazzale Menghini 1, 06132, Perugia, PG, Italy. atlosito@tin.it. 2. Renal Unit, Santa Maria Della Misericordia Hospital, Piazzale Menghini 1, 06132, Perugia, PG, Italy. 3. Department of Clinical and Experimental Medicine, Institute of Geriatrics and Gerontology, Ospedale S. Maria della Misericordia, University of Perugia, Perugia, Italy. 4. Department of Medicine, Hospital of Pantalla, Todi, Italy.
Abstract
BACKGROUND: The cardiovascular risk associated with an increase in serum creatinine below the acute kidney injury (AKI) threshold, during hospitalization, has not been studied in depth. We assessed patients' features and outcomes associated with these changes. METHODS: Retrospective cohort study of 12,493 consecutive patients admitted to hospital throughout 12 months. We investigated the patients who had a small creatinine increase (SISCr) between 1.2 and <1.5 times the admission value, and tested the association of creatinine changes with the prevalence of cardiovascular disease (CVD). In a follow-up study, we assessed the all-cause mortality and its relationship with SISCr. RESULTS: Among patients with two or more creatinine measurements, 14.9% showed a SISCr. Older age, female gender and higher estimated glomerular filtration rate (eGFR) at admission were characteristics of these patients. The prevalence of CVD was 14.6% in patients with SISCr vs. 10.7% in those with stable creatinine (p < 0.001). SISCr was detected in 36, 26.6 and 18.9% of chronic heart failure (CHF), chronic ischemic heart disease (CIHD) and acute myocardial infarction (AMI) patients, respectively. The follow-up was 26.7 ± 10.6 months with 770 all-cause deaths. Serum creatinine increase above 20% was associated with a significant higher mortality compared to changes below 20%, adjusted hazard (HR) ratio 1.577 (p < 0.001). A higher risk was found associated with creatinine increases >1.5 times the baseline: HR 1.704 (p < 0.001). CONCLUSIONS: In hospitalized patients, increases in serum creatinine below the AKI threshold are associated with CHF, CIHD and long-term mortality.
BACKGROUND: The cardiovascular risk associated with an increase in serum creatinine below the acute kidney injury (AKI) threshold, during hospitalization, has not been studied in depth. We assessed patients' features and outcomes associated with these changes. METHODS: Retrospective cohort study of 12,493 consecutive patients admitted to hospital throughout 12 months. We investigated the patients who had a small creatinine increase (SISCr) between 1.2 and <1.5 times the admission value, and tested the association of creatinine changes with the prevalence of cardiovascular disease (CVD). In a follow-up study, we assessed the all-cause mortality and its relationship with SISCr. RESULTS: Among patients with two or more creatinine measurements, 14.9% showed a SISCr. Older age, female gender and higher estimated glomerular filtration rate (eGFR) at admission were characteristics of these patients. The prevalence of CVD was 14.6% in patients with SISCr vs. 10.7% in those with stable creatinine (p < 0.001). SISCr was detected in 36, 26.6 and 18.9% of chronic heart failure (CHF), chronic ischemic heart disease (CIHD) and acute myocardial infarction (AMI) patients, respectively. The follow-up was 26.7 ± 10.6 months with 770 all-cause deaths. Serum creatinine increase above 20% was associated with a significant higher mortality compared to changes below 20%, adjusted hazard (HR) ratio 1.577 (p < 0.001). A higher risk was found associated with creatinine increases >1.5 times the baseline: HR 1.704 (p < 0.001). CONCLUSIONS: In hospitalized patients, increases in serum creatinine below the AKI threshold are associated with CHF, CIHD and long-term mortality.
Authors: Glenn M Chertow; Elisabeth Burdick; Melissa Honour; Joseph V Bonventre; David W Bates Journal: J Am Soc Nephrol Date: 2005-09-21 Impact factor: 10.121
Authors: Amit P Amin; John A Spertus; Kimberly J Reid; Xiao Lan; Donna M Buchanan; Carole Decker; Frederick A Masoudi Journal: Am Heart J Date: 2010-12 Impact factor: 4.749
Authors: Jennie Lin; Hilda Fernandez; Michael G S Shashaty; Dan Negoianu; Jeffrey M Testani; Jeffrey S Berns; Chirag R Parikh; F Perry Wilson Journal: Clin J Am Soc Nephrol Date: 2015-09-03 Impact factor: 8.237
Authors: Amit P Amin; Adam C Salisbury; Peter A McCullough; Kensey Gosch; John A Spertus; Lakshmi Venkitachalam; Joshua M Stolker; Chirag R Parikh; Frederick A Masoudi; Phillip G Jones; Mikhail Kosiborod Journal: Arch Intern Med Date: 2012-02-13
Authors: Kevin Damman; Mattia A E Valente; Adriaan A Voors; Christopher M O'Connor; Dirk J van Veldhuisen; Hans L Hillege Journal: Eur Heart J Date: 2013-10-27 Impact factor: 29.983
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Puneeta Tandon; Matthew T James; Juan G Abraldes; Constantine J Karvellas; Feng Ye; Neesh Pannu Journal: PLoS One Date: 2016-08-09 Impact factor: 3.240
Authors: Luca Di Lullo; Giovanni Tripepi; Claudio Ronco; Antonio De Pascalis; Vincenzo Barbera; Antonio Granata; Domenico Russo; Biagio Raffaele Di Iorio; Ernesto Paoletti; Maura Ravera; Maria Fusaro; Antonio Bellasi Journal: J Nephrol Date: 2018-06-07 Impact factor: 3.902
Authors: Antonio Bellasi; Paolo Raggi; Jordi Bover; David A Bushinsky; Glenn M Chertow; Markus Ketteler; Mariano Rodriguez; Smeeta Sinha; Carolina Salcedo; Rekha Garg; Alex Gold; Joan Perelló Journal: Clin Kidney J Date: 2019-10-30